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Edited by Christian GriesingerAbstract Triglyceride turnover in the isolated C57/BL6 mouse
heart was measured by dynamic 13C edit-1H observe NMR and
the rate of fatty acid oxidation was determined by 13C NMR iso-
topomer analysis. In the presence of a physiological mixture of
substrates, energy was produced in the citric acid cycle by oxida-
tion of long-chain fatty acids (18%), ketones (34%), lactate
(24%), pyruvate (7%), and other sources (17%). Exogenous fatty
acids appeared in the triglyceride pool at 0.24 lmol/g dry wt/
min, similar to the rate of oxidation of long-chain fatty acids,
0.16 lmol/g dry wt/min. Isoproterenol decreased the rate of de
novo triglyceride synthesis and increased the rate of fatty acid
oxidation.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The main pathways of long-chain fatty acid metabolism in
the heart are well-deﬁned. After transport across the sarco-
lemma, long-chain fatty acids are activated by fatty acyl-
CoA synthase and the resulting long-chain fatty acyl-CoA is
either converted to fatty acyl carnitine by carnitine palmitoyl
transferase I and subsequently oxidized in the mitochondria
or esteriﬁed to triglyceride by glycerolphosphate acyl-transfer-
ase [1]. It has long been known that this triglyceride pool can
be mobilized quickly by the normal heart [2,3], and abnormal
triglyceride content has been described in numerous diseases
including ischemia [4,5], diabetes [6] and mouse models of
obesity [7]. However, it is only recently that causal links
between abnormal triglyceride content and left ventricular
dysfunction [7], muscle insulin resistance [8], or apoptosis [9]
have been postulated.
In spite of the potential importance of endogenous triglycer-
ides in disease, the kinetics of triglyceride turnover and the par-*Corresponding author.
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e,
he Federtitioning of fatty acids between storage and oxidation have not
been widely examined. One experimental approach, biochemi-
cal measurement of triglycerides in tissue extracts, is not suit-
able for monitoring triglyceride turnover or for studies in
functioning hearts. Therefore, many investigations of cardiac
triglyceride turnover relied on monitoring glycerol release
[10,11] or by detection of 14CO2 after prelabeling of the endog-
enous lipid pools with radioactive fatty acids [12,13]. More re-
cently, dynamic 13C NMR was used to directly detect de novo
synthesis of cardiac triglycerides from enriched palmitate [14].
Nevertheless, the overall balance between lipolysis and synthe-
sis in response to simple interventions such as catecholamines
remains uncertain. For example, lipolysis as measured by glyc-
erol release or reduction of triglyceride mass is stimulated by
catecholamines [11,12], but isoproterenol also increases triglyc-
eride synthesis and causes accumulation of myocardial triglyc-
erides in vivo [15,16].
The ability to non-invasively monitor triglyceride synthesis
and degradation in the heart and other tissues without radiotra-
cers would have wide clinical and research applications. The
goal of the present study was to determine the fate of long-
chain fatty acids entering a C57/BL6 mouse heart supplied with
a physiologically relevant mixture of substrates. Since NMR
detection of triglycerides by 1H spectroscopy by NMR is more
sensitive than direct 13C detection, an inverse detection method
was applied. Conventional 13C NMR isotopomer analysis was
used to determine the rate of oxidation of fatty acids by hearts
and the fraction of cardiac triglycerides enriched in 13C was
determined by the spin-coupled satellites observed in 1H
NMR spectra of extracted triglycerides. Fatty acids entering
the triglyceride pool were followed directly with high temporal
resolution to determine the rate of triglyceride turnover as well
as dynamic response to the b agonist, isoproterenol.2. Materials and methods
2.1. Materials
[1,3-13C2]Ethyl acetoacetate, [3-
13C]sodium lactate, [U-13C3]sodium
lactate, [3-13C]sodium pyruvate, and a mixture of [U-13C]long-chain
fatty acids were obtained from Cambridge Isotope Laboratories, Inc.
(Andover, MA). Triglyceride assay kits and glycerol standard were ob-
tained from Sigma Chemical Co. (St. Louis, MO). Sep-Pak Vac RC
cartridges were obtained from Waters Co. (WAT036950, Milford,
MA). DL-Isoproterenol hydrochloride and all other chemicals wereation of European Biochemical Societies.
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er Laboratories (Wilmington, MA) and given free access to standard
mouse chow and water.
2.2. Heart perfusions
Protocols were approved by the Institutional Animal Care and Use
Committee. Hearts from adult female mice were rapidly excised under
general anesthesia and perfused using standard Langendorﬀ methods
at 37 C and 100 cm H2O. The modiﬁed Krebs–Henseleit (KH) buﬀer
was bubbled continuously with a 95/5 mixture of O2/CO2, and con-
tained 118 mM NaCl, 4.7 mM KCl, 25 mM NaHCO3, 1.2 mM
MgSO4, 2.5 mM CaCl2, 8.2 mM glucose, 0.13 mM glycerol, 4.9 mM
lactate, 0.49 mM pyruvate, 0.28 mM acetoacetate, 0.63 mM long-chain
fatty acids, and 2% albumin. These are the average plasma substrate
concentrations reported for resting mice [17–25]. The heart rate was
monitored through an open-ended cannula in the left ventricle.
2.3. Isotopomer analysis from tissue extracts
Eight hearts were supplied for 45 min with non-recirculating med-
ium containing [U-13C]long-chain fatty acids, [3-13C]lactate,
[3-13C]pyruvate, and [1,3-13C2]acetoacetate. As a result, [1,2-
13C2]ace-
tyl-CoA will be generated only from the fatty acids. Lactate and pyru-
vate will both produce [2-13C]acetyl-CoA, acetoacetate will provide
[1-13C]acetyl-CoA, and unenriched acetyl-CoA can arise from utiliza-
tion of glucose, glycerol, and/or endogenous substrates. Three addi-
tional hearts were perfused using the same protocol and enrichment
patterns with the addition of 1 lM isoproterenol to the buﬀer. In a
third group, eight hearts were supplied with medium containing
[U-13C]long-chain fatty acids, [U-13C3]lactate, [3-
13C]pyruvate, and
[1,3-13C2]acetoacetate. In this series the fatty acids and lactate will both
generate [1,2-13C2]acetyl-CoA. Since [3-
13C]pyruvate is the only source
of [2-13C]acetyl-CoA, the oxidation of lactate and pyruvate can be
determined separately. Oxygen consumption was determined using
coronary ﬂow measurements and the diﬀerence in pO2 between the
arterial perfusate and the coronary eﬄuent (Instrumentation Labora-
tory, Lexington, MA). Hearts were freeze-clamped after 45 min and
stored at 70 C. Two hearts perfused using the same conditions were
combined to increase the amount of glutamate. Tissue was extracted
with perchloric acid and resuspended in 0.6 mL 2H2O for NMR spec-
troscopy [26]. Citric acid cycle ﬂux was determined using isotopomer
analysis and O2 consumption.
2.4. Direct observation of triglyceride turnover
Hearts were cannulated, supplied with non-recirculating KH med-
ium with unenriched fatty acids and all other substrates, and placed
in an 8 mm NMR tube. The water-jacketed, two-chamber glass perfu-
sion apparatus was maintained at 37 C and the entire apparatus ﬁt
into the bore of a 14.1 T magnet. During a stabilization time of
approximately 20 min, the NMR probe was tuned and the ﬁeld homo-
geneity was optimized. After the collection of kinetic data was started,
the perfusing medium was switched to a second chamber containing
the same substrates but with [U-13C]long-chain fatty acids substituted
for unenriched long-chain fatty acids. One heart was freeze-clamped
every 8–9 min from 30 to 110 min after switchover, and stored
(n = 10 hearts). Frozen tissue was ground into a ﬁne powder under li-
quid nitrogen, and then the lipids were extracted [27]. Triglyceride con-
tent was determined using a colorimetric assay (TR0100, Sigma) [28].
Triglycerides were separated from other lipids on a prepacked silica
Sep-Pak column using combinations of methyl-t-butylether and hexene
as described by Hamilton and Comai [29]. Another group of ﬁve hearts
was perfused using the same protocol; however, after the hearts were
given [U-13C]long-chain fatty acids for 30 min the perfusate was chan-
ged again and 1 lM isoproterenol was added. After NMR data collec-
tion for 30 min, the hearts were freeze-clamped and extracted as
described above.
2.5. NMR spectroscopy
All spectra were collected using a Varian INOVA 14.1 T spectrom-
eter. WET-HMQC (water suppression enhanced through T1 eﬀects -
heteronuclear multiple quantum coherence) NMR spectra of isolated
mouse hearts [30] were acquired in an 8 mm inverse detection probe
equipped with pulsed ﬁeld gradient coils (Nalorac, Martinez, CA).
An acquisition time of 0.3 s was used and 1823 points were recordedover 6000 Hz. Each spectrum was the sum of 48 transients obtained
in 67 s. 13C {1H} NMR spectra of tissue extracts were acquired at
25 C within a 5 mm Varian broad-band probe using a 45 pulse with
a 1.3 s acquisition time and 1 s delay for a total pulse repetition time of
2.3 s, and bi-level WALTZ-16 decoupling [26,30]. The relative areas of
the 13C NMR multiplets were used to determine the fractional contri-
bution to acetyl-CoA from each 13C-enriched substrate as well as rel-
ative anaplerotic ﬂux [y] [26,31]. 1H NMR spectra of triglycerides
extracted from heart tissue extracts were acquired at 600 MHz using
a 5 mm indirect detection probe. Spectra were collected using a 90
pulse with a 1 s delay. The 13C satellites in the methyl resonance cen-
tered at 0.88 ppm were used to determine triglyceride 13C enrichment.3. Results
3.1. Sources of acetyl-CoA and citric acid cycle ﬂux
Multiplets due to 13C–13C spin–spin coupling were easily re-
solved in the 13C NMR spectra of heart extracts (Fig. 1). The
contribution of exogenous substrates to acetyl-CoA was fatty
acids, 18 ± 6%; ketones, 34 ± 7%; lactate, 24 ± 4%; or pyru-
vate, 7 ± 4%. (All data are reported as mean ± 1 S.D.) By dif-
ference, the contribution of unlabeled acetyl-CoA (from
glucose, glycerol, glycogen, and endogenous triglycerides)
was 17%. The average anaplerotic ﬂux as a fraction of citric
acid cycle ﬂux, y, was 8 ± 3%. In the same group of hearts,
O2 consumption was 18.7 ± 4.1 lmol O2/min/g dry wt.
The proportionality constant between citric acid cycle ﬂux
and oxygen consumption is substrate-dependent due to the dif-
fering number of reducing equivalents produced outside the
cycle. Since the 13C NMR isotopomer analysis provides the
fraction of acetyl-CoA derived from a particular substrate,
reducing equivalents produced outside the cycle relative to
those produced from the citric acid cycle itself is easily deter-
mined [31]. From this information plus the measured oxygen
consumption, ﬂux through citrate synthase was
7.2 ± 1.9 lmol/g dry wt/min, and the rate of oxidation of exog-
enous long-chain fatty acids equivalent to palmitate was (cit-
rate synthase ﬂux) · (fraction of acetyl-CoA derived from
fatty acids)/8, or 0.16 lmol/g dry wt/min.
3.2. 13C enrichment in triglycerides by tissue extracts
The concentration of triglycerides in the hearts at the end of
the 100-min perfusion period measured chemically was
38 ± 10 lmol/g dry wt. Hearts were freeze-clamped at 9 min
intervals from 30 to 110 min after switching to 13C-enriched
fatty acids (n = 10 hearts). The rate of 13C enrichment of the
triglyceride pool, measured by 1H NMR of tissue extracts,
was approximately linear, % enrichment = 0.18t + 2.9,
r2 = 0.43, where t is time in min from switchover. At
100 min, about 21% of cardiac triglycerides were 13C enriched.
Therefore, the rate of appearance of 13C-enriched fatty acids in
the triglyceride pool was 0.24 lmol fatty acids/g dry wt/min
(equivalent to 0.08 lmol triglycerides/g dry wt/min).
3.3. 1H NMR observation of triglyceride turnover in the beating
heart
No signal from fatty acids could be detected from
[U-13C]long-chain fatty acids in the medium by WET-HMQC,
presumably because of low concentration or NMR ‘‘invisibil-
ity’’ due to binding to albumin. Small resonances due to natu-
ral abundance 13C in triglycerides were detected in isolated
hearts supplied with unlabeled long-chain fatty acids. Hearts
were switched to a perfusate containing [U-13C]long-chain
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Fig. 1. 1H decouple-13C NMR spectrum of a heart extract. Resonance
assignments are shown in the lower panel. Abbreviations: D, doublet
in carbon 3 resonance due to either J2,3 or J3,4; D34, doublet in carbon
4 due to J3,4; D45, doublet in carbon 4 due to J4,5; S, singlet; Su,
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Fig. 3. 1D WET-HMQC over the 2.5–0.9 ppm region from an isolated
mouse heart supplied with [U-13C]fatty acids plus unlabeled lactate,
pyruvate, glycerol, glucose, and ketones. Chemical shift assignments
are shown in Fig. 2.
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nous triglyceride pool. The 1 D WET-HMQC spectrum of la-
beled triglycerides including chemical shift assignments [32] is
shown in Fig. 2 and the full stacked plot is shown in Fig. 3.
The appearance of 13C-enriched fatty acids in the triglycer-
ide pool could represent de novo synthesis or turnover of a tri-
glyceride pool with ﬁxed mass. In separate experiments with
hearts supplied with unenriched fatty acids, the natural abun-
dance 13C triglyceride signal was constant over 2 h. In addi-
tional studies with hearts supplied with enriched fatty acids,
followed by switchover to unenriched fatty acids, the 13C sig-
nal remained constant or decreased slightly (data not shown).-(CH2)-
-CH3
COO-CH2-CH2
CH2-CH=CH-CH2
COO-CH2-
=CH-CH2-CH=
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Fig. 2. Selected 1D WET-HMQC spectra of triglyceride region. Each
spectrum was acquired over 67 s.Therefore, the appearance of 13C-enriched triglycerides reﬂects
turnover in a triglyceride pool of constant mass with rate con-
stant of 0.0024 min1.
In other studies, addition of isoproterenol (1 lM) caused an
increase in heart rate (from 340 to 480 beats/min) and a de-
crease in the rate of 13C appearance in the triglyceride pool,
Fig. 4, to about 33% of the original rate (slope of 1.39 ± 0.07
vs. 0.47 ± 0.15 U/min). In these hearts, fatty acids contributedTime (min)
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Fig. 4. Enrichment of the triglyceride peaks over the 2.5–0.9 ppm
region as monitored by 1D WET-HMQC. Spectra were averaged over
67 s intervals. The ﬁrst 30 min followed the enrichment in a
[U-13C]long-chain fatty acid-perfused heart. The spectra from 30–
60 min were obtained after the addition of isoproterenol (triangle)
compared to control hearts (square).
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hearts.4. Discussion
These studies demonstrate that triglyceride turnover is easily
monitored in the mouse heart using an inverse detection meth-
od. Given the small mass of the mouse heart, the observed high
signal-to-noise, and the fact that only a small fraction of fatty
acids need be enriched to detect triglyceride turnover, this
method shows promise for in vivo systems and human applica-
tions. Of course there are many potential diﬃculties of imple-
menting WET-HMQC in vivo, particularly in the moving
heart. This technique may be more suitable for relatively
homogeneous solid organs such as the liver where abnormal
fat stores are critically important in genesis of steatohepatitis
and fatty liver disease [33], or in skeletal muscle where abnor-
mal fat metabolism may cause insulin resistance [8]. Conven-
tional 13C NMR isotopomer analysis relies on analysis of the
spin–spin coupling patterns that encode metabolic ﬂux infor-
mation. Unlike this technique, detection of triglyceride kinetics
would not depend on replacing a signiﬁcant fraction of the
unlabeled with labeled plasma fatty acids.
In these hearts fatty acids were oxidized at approximately the
same rate as incorporation into triglycerides (0.16 and
0.24 lmol/g dry wt/min, respectively). These data indicate that
when fatty acids enter the heart and mechanical demand is low,
about 60% are esteriﬁed and the remaining 40% proceed to di-
rect oxidation in the TCA cycle. The rate of 13C appearance in
triglycerides decreased signiﬁcantly (see Fig. 4) after exposure
to isoproterenol. The 13C signal is a function of triglyceride
mass, 13C enrichment in the triglycerides, and NMR relaxation
times (T1 and T2) of the triglycerides. Since serial biochemical
measurements of triglyceride mass over time were not practical,
it is not possible to distinguish reduction of the mass of stored
triglyceride from reduced turnover in the triglyceride pool.
Since the fraction of acetyl-CoA derived from fatty acids in-
creased from 18% to 27% after isoproterenol, it is likely that un-
der increased workload, exogenous fatty acids are shunted
away from triglycerides and preferentially oxidized.
Direct measurement of acetyl-CoA labeling and triglyceride
enrichment demonstrates that the pool of cytosolic fatty acyl-
CoA supplying b oxidation is not in isotopic equilibrium with
the triglyceride pool. By the end of the perfusion period, tri-
glycerides were enriched to about 21% in [U-13C]fatty acids.
If the entire triglyceride pool was in isotopic equilibrium with
cytosolic fatty acyl-CoA, then 21% of the entire pool would
have been 13C enriched while 79%, unenriched. However, com-
bined with the observation that 18% of all acetyl-CoA entering
the TCA cycle was derived from 13C-enriched fatty acids and if
the entire triglyceride pool is in dynamic equilibrium with
long-chain acyl-CoA’s contributing to b-oxidation, then fatty
acids actually contribute 86% of all of acetyl-CoA entering
the TCA cycle (18% from 13C-enriched fats and 68% from
unenriched fatty acids). This conclusion is obviously not con-
sistent with the observation that lactate, pyruvate, and ketones
contributed 65% of acetyl-CoA. Therefore, one must conclude
that the triglyceride pool is not in complete equilibrium with
long-chain acyl-CoA’s entering the cell and destined for oxida-
tion even after 100 min of continued perfusion. This observa-
tion is consistent with numerous previous reports of multipletypes of triglyceride pools in heart tissue each characterized
by diﬀerent turnover rates [3,13,34].
Fatty acids generally are considered the preferred substrate
for the heart [1,35]. However, some reports concluded that lac-
tate is preferred, based upon suppression of fatty acid utiliza-
tion after an increase in lactate concentration [36,37], and
others [35] ﬁnd that ketones are the preferred substrate even
at the low concentration found in vivo, 0.17 mM. More re-
cently, Ziegler et al. found that ketones at high concentration,
1.6 mM, contributed about 40% of the acetyl-CoA oxidized in
the myocardium in vivo [38]. In fact, it is diﬃcult to resolve
these competing claims due to variations in substrate concen-
trations under study and because many early experiments
examined competition between only two substrates, presum-
ably because of the technical diﬃculties in measuring utiliza-
tion of multiple substrates at once.
This study for the ﬁrst time employed this group of sub-
strates (acetoacetate, glucose, glycerol, lactate, pyruvate, and
long-chain fatty acids) to assess substrate selection in the iso-
lated mouse heart. In contrast to studies that rely on measur-
ing substrate concentration gradients across the heart, tracer
dilution, respiratory quotient or 14CO2 release,
13C NMR iso-
topomer analysis unequivocally identiﬁes relative substrate
oxidation from multiple substrates simultaneously since it de-
tects the labeling of a metabolic product in the TCA cycle.
For example, it is easily seen (Fig. 1) that the contribution of
lactate to acetyl-CoA is about twice that of long-chain fatty
acids, a result likely due to the concentration of substrates in
the perfusate. An additional ﬁnding is that acetoacetate is used
to a substantial degree, contributing 34% of acetyl-CoA at nor-
mal plasma concentrations. The fact that acetoacetate contrib-
uted such a high proportion of the oxidized substrate, even at
0.28 mM compared to the relatively high concentration of
competing substrates, indicates that ketones are the preferred
substrate for energy production in the normal mouse heart
in vivo. Studies in rats where with 13C-enriched acetate and ke-
tones were co-infused also found a substantial contribution of
ketones to cardiac energy production in vivo [38].
The phrase ‘‘substrate preference’’, widely used in cardiac
physiology, is somewhat ambiguous since some studies com-
pared oxidation of two substrates, others examined oxidation
of a single substrate in vivo, and others assessed the suppres-
sion of competing substrates after the concentration of sub-
strate is increased. Earlier we suggested that a better index
may be to compare substrate oxidation on the basis of sub-
strate concentration [35]. In the current study, the ratio (% oxi-
dation)/(concentration) was long-chain fatty acids (29),
acetoacetate (121), lactate (4.9), and pyruvate (1.4). After cor-
rection for concentration, acetoacetate was overwhelmingly
the preferred substrate.
Although earlier reports indicate that isoproterenol results
in long-term accumulation of myocardial triglycerides, the
present kinetic results shows that isoproterenol slows entry
of [U-13C]acyl-CoA into the triglyceride pool of mouse hearts
and shifts the fate of [U-13C]acyl-CoA toward b-oxidation
likely due to an increased energy demand. These results are
not necessarily incongruent because our kinetic data were col-
lected only over a period of 30 min after isoproterenol
administration. Thus, the acute eﬀect of isoproterenol admin-
istration appears to be a shift in fatty acid utilization away
from triglyceride storage and toward oxidation while the
chronic eﬀect likely shifts back toward triglyceride accumula-
4286 K.A. Stowe et al. / FEBS Letters 580 (2006) 4282–4287tion as the heart adjusts to an increased metabolic energy de-
mand by using other substrates for energy production or be-
cause of changes in fatty acid delivery to the heart due to
systemic eﬀects of adrenergic stimulation. This apparent
dichotomy highlights the importance of dynamic measures of
triglyceride turnover using techniques such as that described
here.
In summary, inverse detection NMR methods are useful for
monitoring the rapid turnover of myocardial triglycerides with
high sensitivity and superb temporal resolution. Given the
strong interest in understanding the role of triglyceride stores
in metabolism and insulin resistance, exploration of these
methods in vivo is warranted. In the presence of a mixture
of physiological substrates, long-chain fatty acids unexpectedly
contributed less to energy production in the mouse heart than
is generally accepted.
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